---
format: "aidr-story-markdown/v1"
id: "b86656ae35551cde18161a4855a5d4dd3e8e744bf7d6dc5efe9cdbe1495028b8"
canonical_url: "https://aidr.today/b86656ae?lang=en"
title: "Pathos AI, which uses AI to develop oncology drugs, raised a $237M Series E at a $3B post-money valuation, up from a $1.6B valuation in May 2025 (Katherine Davis/Axios)"
lang: "en"
requested_lang: "en"
available_langs: ["en","vi"]
translation_fallback: null
fallback_fields: []
published_at: "2026-10-23T12:40:01.000Z"
category: "Funding"
topics: ["funding"]
source_urls: ["https://www.techmeme.com/261023/p9"]
summary: "Pathos AI, a precision oncology biotech using AI to develop drugs, raised $237 million in a Series E round at a $3 billion post-money valuation, up from $1.6 billion in May 2025."
---

# Pathos AI, which uses AI to develop oncology drugs, raised a $237M Series E at a $3B post\-money valuation, up from a $1\.6B valuation in May 2025 \(Katherine Davis/Axios\)

> [Open the canonical story](<https://aidr.today/b86656ae?lang=en>)

**Published:** 2026-10-23T12:40:01.000Z
**Category:** Funding
**Topics:** funding

## Summary

Pathos AI, a precision oncology biotech using AI to develop drugs, raised $237 million in a Series E round at a $3 billion post\-money valuation, up from $1\.6 billion in May 2025\.

## Sources

- [Story source](<https://www.techmeme.com/261023/p9>)